Nkarta Inc. (NKTX): Price and Financial Metrics
NKTX Price/Volume Stats
| Current price | $2.50 | 52-week high | $16.24 |
| Prev. close | $2.48 | 52-week low | $2.38 |
| Day low | $2.40 | Volume | 1,000,700 |
| Day high | $2.54 | Avg. volume | 1,147,659 |
| 50-day MA | $3.92 | Dividend yield | N/A |
| 200-day MA | $6.79 | Market Cap | 176.42M |
NKTX Stock Price Chart Interactive Chart >
Nkarta Inc. (NKTX) Company Bio
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
NKTX Price Returns
| 1-mo | -39.90% |
| 3-mo | -53.01% |
| 6-mo | -61.18% |
| 1-year | -3.47% |
| 3-year | -85.73% |
| 5-year | N/A |
| YTD | -62.12% |
| 2023 | 10.18% |
| 2022 | -60.98% |
| 2021 | -75.03% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...